Chembio Diagnostics Reports First Quarter 2021 Financial Results
May 06, 2021 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021
April 22, 2021 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu
April 01, 2021 17:30 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., April 01, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the...
Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results
March 11, 2021 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors
March 08, 2021 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., March 08, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the...
Chembio Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
February 25, 2021 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems
January 14, 2021 07:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the CE mark...
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
December 17, 2020 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the...
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System
December 02, 2020 13:22 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious diseases, today announced it has been...
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil
November 13, 2020 16:40 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that its...